| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC1584 |
| Trial ID | NCT02663297 |
| Disease | Hodgkin's Lymphoma | Lymphoproliferative Syndrome | Immune System Disease | Neoplasm | Lymphoma | Non-Hodgkin's Lymphoma | Lymphatic System Disease |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ATLCAR.CD30 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Administration of T Lymphocytes for Prevention of Relapse of Lymphomas |
| Year | 2016 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC 1524-ATL|R01HL114564 |
| Cohort 1 | |||||||||||
|
|||||||||||